1. Home
  2. VSTM vs FFIC Comparison

VSTM vs FFIC Comparison

Compare VSTM & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • FFIC
  • Stock Information
  • Founded
  • VSTM 2010
  • FFIC 1929
  • Country
  • VSTM United States
  • FFIC United States
  • Employees
  • VSTM N/A
  • FFIC N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • FFIC Major Banks
  • Sector
  • VSTM Health Care
  • FFIC Finance
  • Exchange
  • VSTM Nasdaq
  • FFIC Nasdaq
  • Market Cap
  • VSTM 425.9M
  • FFIC 415.1M
  • IPO Year
  • VSTM 2012
  • FFIC 1995
  • Fundamental
  • Price
  • VSTM $4.17
  • FFIC $11.94
  • Analyst Decision
  • VSTM Strong Buy
  • FFIC Hold
  • Analyst Count
  • VSTM 9
  • FFIC 3
  • Target Price
  • VSTM $12.63
  • FFIC $16.17
  • AVG Volume (30 Days)
  • VSTM 2.6M
  • FFIC 227.7K
  • Earning Date
  • VSTM 08-07-2025
  • FFIC 07-24-2025
  • Dividend Yield
  • VSTM N/A
  • FFIC 7.35%
  • EPS Growth
  • VSTM N/A
  • FFIC N/A
  • EPS
  • VSTM N/A
  • FFIC N/A
  • Revenue
  • VSTM $10,000,000.00
  • FFIC $124,028,000.00
  • Revenue This Year
  • VSTM $129.06
  • FFIC $112.30
  • Revenue Next Year
  • VSTM $306.32
  • FFIC $7.61
  • P/E Ratio
  • VSTM N/A
  • FFIC N/A
  • Revenue Growth
  • VSTM N/A
  • FFIC N/A
  • 52 Week Low
  • VSTM $2.10
  • FFIC $10.65
  • 52 Week High
  • VSTM $9.10
  • FFIC $18.59
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 25.74
  • FFIC 48.29
  • Support Level
  • VSTM $4.43
  • FFIC $11.30
  • Resistance Level
  • VSTM $6.62
  • FFIC $12.19
  • Average True Range (ATR)
  • VSTM 0.30
  • FFIC 0.31
  • MACD
  • VSTM -0.16
  • FFIC 0.00
  • Stochastic Oscillator
  • VSTM 4.20
  • FFIC 53.68

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

Share on Social Networks: